162 related articles for article (PubMed ID: 36660647)
1. Characterization of osteosarcoma subtypes mediated by macrophage-related genes and creation and validation of a risk score system to quantitatively assess the prognosis of osteosarcoma and reflect the tumor microenvironment.
Liu Z; Zhang L; Zhong Y
Ann Transl Med; 2022 Dec; 10(24):1318. PubMed ID: 36660647
[TBL] [Abstract][Full Text] [Related]
2. Immunogenic cell death related mRNAs associated signature to predict immunotherapeutic response in osteosarcoma.
Han S; Wang Q; Shen M; Zhang X; Wang J
Heliyon; 2024 Mar; 10(6):e27630. PubMed ID: 38515694
[TBL] [Abstract][Full Text] [Related]
3. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
4. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.
Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L
Front Oncol; 2022; 12():941724. PubMed ID: 36212395
[TBL] [Abstract][Full Text] [Related]
5. Identification and characterization of aging/senescence-induced genes in osteosarcoma and predicting clinical prognosis.
Lv Y; Wu L; Jian H; Zhang C; Lou Y; Kang Y; Hou M; Li Z; Li X; Sun B; Zhou H
Front Immunol; 2022; 13():997765. PubMed ID: 36275664
[TBL] [Abstract][Full Text] [Related]
6. The hexosamine biosynthesis pathway-related gene signature correlates with immune infiltration and predicts prognosis of patients with osteosarcoma.
Su Z; Wang C; Pan R; Li H; Chen J; Tan J; Tian X; Lin T; Shen J
Front Immunol; 2022; 13():1028263. PubMed ID: 36275679
[TBL] [Abstract][Full Text] [Related]
7. A tumor microenvironment-based prognostic index for osteosarcoma.
Wu C; Gong S; Duan Y; Deng C; Kallendrusch S; Berninghausen L; Osterhoff G; Schopow N
J Biomed Sci; 2023 Apr; 30(1):23. PubMed ID: 37055822
[TBL] [Abstract][Full Text] [Related]
8. Autophagy-related gene expression classification defines three molecular subtypes with distinct clinical and microenvironment cell infiltration characteristics in colon cancer.
Zhu S; Wu Q; Zhang B; Wei H; Li B; Shi W; Fang M; Zhu S; Wang L; Lang Zhou Y; Dong Y
Int Immunopharmacol; 2020 Oct; 87():106757. PubMed ID: 32769067
[TBL] [Abstract][Full Text] [Related]
9. Molecular typing and prognostic model of lung adenocarcinoma based on cuprotosis-related lncRNAs.
Zheng M; Zhou H; Xie J; Zhang H; Shen X; Zhu D
J Thorac Dis; 2022 Dec; 14(12):4828-4845. PubMed ID: 36647499
[TBL] [Abstract][Full Text] [Related]
10. Classification of molecular subtypes for colorectal cancer and development of a prognostic model based on necroptosis-related genes.
Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
Heliyon; 2024 Mar; 10(5):e26781. PubMed ID: 38439879
[TBL] [Abstract][Full Text] [Related]
11. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
12. A novel signature to guide osteosarcoma prognosis and immune microenvironment: Cuproptosis-related lncRNA.
Yang M; Zheng H; Xu K; Yuan Q; Aihaiti Y; Cai Y; Xu P
Front Immunol; 2022; 13():919231. PubMed ID: 35967366
[TBL] [Abstract][Full Text] [Related]
13. Identification and Development of a Novel 4-Gene Immune-Related Signature to Predict Osteosarcoma Prognosis.
Cao M; Zhang J; Xu H; Lin Z; Chang H; Wang Y; Huang X; Chen X; Wang H; Song Y
Front Mol Biosci; 2020; 7():608368. PubMed ID: 33425993
[TBL] [Abstract][Full Text] [Related]
14. Single-cell RNA datasets and bulk RNA datasets analysis demonstrated
Tu J; Wang D; Zheng X; Liu B
Front Immunol; 2023; 14():911368. PubMed ID: 36814925
[TBL] [Abstract][Full Text] [Related]
15. Subtype Classification and Prognosis Signature Construction of Osteosarcoma Based on Cellular Senescence-Related Genes.
Wang H; Liu H; Wang L; Xu S; Pi H; Cheng Z
J Oncol; 2022; 2022():4421952. PubMed ID: 36106335
[TBL] [Abstract][Full Text] [Related]
16. Identification of Hypoxia-Related Subtypes, Establishment of Prognostic Models, and Characteristics of Tumor Microenvironment Infiltration in Colon Cancer.
Wang C; Tang Y; Ma H; Wei S; Hu X; Zhao L; Wang G
Front Genet; 2022; 13():919389. PubMed ID: 35783281
[No Abstract] [Full Text] [Related]
17. Construction and Validation of a Tumor Microenvironment-Based Scoring System to Evaluate Prognosis and Response to Immune Checkpoint Inhibitor Therapy in Lung Adenocarcinoma Patients.
Huang P; Xu L; Jin M; Li L; Ke Y; Zhang M; Zhang K; Lu K; Huang G
Genes (Basel); 2022 May; 13(6):. PubMed ID: 35741714
[TBL] [Abstract][Full Text] [Related]
18. Tumor microenvironment phenotypes and prognostic evaluation tools for osteosarcoma characterized by different prognostic outcomes and immunotherapy responses.
Tu Z; Li W; Chen Z; Jiang D; Zhou S; Lv S; Cui H
J Gene Med; 2024 Jan; 26(1):e3572. PubMed ID: 37525871
[TBL] [Abstract][Full Text] [Related]
19. Bioinformatics Analysis Reveals an Association between Autophagy, Prognosis, Tumor Microenvironment, and Immunotherapy in Osteosarcoma.
Ma Y; Tong C; Xu M; He H; Chen C
J Oncol; 2022; 2022():4220331. PubMed ID: 35874628
[TBL] [Abstract][Full Text] [Related]
20. Development of Personalized Signature Based on the Immune Landscape to Predict the Prognosis of Osteosarcoma and the Response to Immunotherapy and Targeted Therapy.
Feng X; Zhao Z; Zhao Y; Song Z; Ma Y; Wang W
Front Mol Biosci; 2021; 8():783915. PubMed ID: 35127816
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
